High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group (Q36115868)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group |
scientific article |
Statements
1 reference
High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group (English)
1 reference
Nielsen OS
1 reference
Dombernowsky P
1 reference
Mouridsen H
1 reference
Crowther D
1 reference
Verweij J
1 reference
Buesa J
1 reference
Steward W
1 reference
Daugaard S
1 reference
van Glabbeke M
1 reference
Kirkpatrick A
1 reference
Tursz T
1 reference
1 December 1998
1 reference
1 reference
1634-1639
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference